Article 89
Law 105/2016/QH13 — Luật Dược số 105/2016/QH13
Clinical trial of drugs
Drugs subject to clinical trial, drugs exempt from clinical trial or from certain stages of clinical trial before registration
1. The following drugs shall undergo all stages of clinical trial:
a/ New drugs, except the cases specified at Point a, Clause 2, and Point b, Clause 3, of this Article;
b/ Drugs from medicinal materials using a new combination of medicinal materials previously used for drug manufacture in Vietnam and for treatment of diseases on the list issued by the Minister of Health, except the cases specified at Point b, Clause 2, and Point c, Clause 3, of this Article;
c/ Vaccines registered for the first time for circulation in Vietnam, except the case specified at Point c, Clause 2 of this Article.
2. The following drugs shall be exempted from certain stages of clinical trial:
a/ New drugs which have certificates of free sale in at least one country in the world but there are no sufficient clinical data on their safety and efficacy;
b/ Drugs from medicinal materials not mentioned at Point c, Clause 3 of this Article;
c/ Vaccines which have certificates of free sale in at least one country in the world and there are clinical data on their safety and efficacy.
3. The following drugs shall be exempted from clinical trial:
a/ Generic drugs;
b/ New drugs which have certificates of free sale in at least one country in the world and there are sufficient clinical data on their safety and efficacy, except vaccines;
c/ Drugs from medicinal materials which have certificates of free sale issued before the effective date of this Law, except drugs for treatment of diseases on the list issued by the Minister of Health.
4. The Minister of Health shall set specific requirements on clinical data to ensure safety and efficacy, and criteria for identifying drugs which are exempt from clinical trial or from certain stages of clinical trial in Vietnam and drugs which must undergo stage 4 of clinical trial.
Article 89, Law 105/2016/QH13